MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

Search

AngioDynamics Inc

Fechado

SetorSaúde

9.84 -9.39

Visão Geral

Variação de preço das ações

24h

Atual

Mín

9.64

Máximo

10.86

Indicadores-chave

By Trading Economics

Rendimento

2.7M

-11M

Vendas

1.9M

73M

EPS

-0.04

Margem de lucro

-14.741

Funcionários

748

EBITDA

3.8M

1.8M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+41.16% upside

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

107M

384M

Abertura anterior

19.23

Fecho anterior

9.84

Sentimento de Notícias

By Acuity

38%

62%

139 / 386 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Strong Bullish Evidence

AngioDynamics Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

9 de dez. de 2024, 15:23 UTC

Grandes Movimentos do Mercado

AngioDynamics Shares at 52-Week High After FDA Clears NanoKnife

9 de dez. de 2024, 15:20 UTC

Grandes Movimentos do Mercado

AngioDynamics Shares at 52-Week High After FDA Clears NanoKnife

4 de abr. de 2024, 14:56 UTC

Ganhos
Grandes Movimentos do Mercado

AngioDynamics Shares Rise 10% After FDA Clears AlphaVac F18 System

Comparação entre Pares

Variação de preço

AngioDynamics Inc Previsão

Preço-alvo

By TipRanks

41.16% parte superior

Previsão para 12 meses

Média 15.33 USD  41.16%

Máximo 16 USD

Mínimo 15 USD

Com base em 3 analistas de Wall Street que oferecem metas de preço de 12 meses para AngioDynamics Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

3 ratings

3

Comprar

0

Manter

0

Vender

Pontuação Técnica

By Trading Central

9.87 / N/ASuporte e Resistência

Curto Prazo

Strong Bullish Evidence

Médio Prazo

Weak Bullish Evidence

Longo Prazo

Weak Bullish Evidence

Sentimento

By Acuity

139 / 386 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre AngioDynamics Inc

AngioDynamics, Inc., a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium. Its thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit, indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. The company also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. In addition, it provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. The company was founded in 1988 and is headquartered in Latham, New York.